Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IRDOpus Genetics, Inc.

Nasdaq · CIK 0001228627
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts391

Identity from submissions API

NameOpus Genetics, Inc.
CIK0001228627
TickersIRD
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN113516358
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(984) 884-6030
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Ocuphire Pharma, Inc. (2020-11-09T05:00:00.000Z → 2024-10-22T04:00:00.000Z)
  • REXAHN PHARMACEUTICALS, INC. (2005-05-16T04:00:00.000Z → 2020-11-09T05:00:00.000Z)
  • CORPORATE ROAD SHOW DOT COM INC (2003-04-30T04:00:00.000Z → 2005-04-29T04:00:00.000Z)
  • FERRARO FRANK (2003-04-29T04:00:00.000Z → 2003-04-29T04:00:00.000Z)
Business address
8 DAVIS DRIVE
SUITE 220
DURHAM
NC
27713
NC
Mailing address
8 DAVIS DRIVE
SUITE 220
DURHAM
NC
27713
NC

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1075 filing rows loaded from submissions recent; extra archives: CIK0001228627-submissions-001.json (75 filings, 2003-04-29 to 2006-05-01).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-463810 005-79996 261562663 34 11960
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-120703 005-79996 261561715 34 12764
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000027 005-79996 261561540 34 10273
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005298 005-79996 261559152 34 11131
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005045 005-79996 261555081 34 15714
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007560 005-79996 261543906 34 12949
2026-11-10 10-Q 10-Q 0001628280-26-072697 001-34079 261540214 34 7516920 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001628280-26-072493 001-34079 261537889 34 246335 1 1
2026-11-05 4 FORM 4 0001140361-26-042102 5747
2026-11-03 144 xsl144X01/primary_doc.xml 0001974078-26-000396 001-34079 261517113 33 5278
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003823 005-79996 261491671 34 11025
2026-10-27 4 FORM 4 0001140361-26-040908 5243
2026-10-27 4 FORM 4 0001140361-26-040906 7684
2026-10-27 4 FORM 4 0001140361-26-040896 6139
2026-10-27 4 FORM 4 0001140361-26-040893 5228
2026-10-23 144 xsl144X01/primary_doc.xml 0001974078-26-000387 001-34079 261482854 33 5338
2026-10-23 144 xsl144X01/primary_doc.xml 0001974158-26-000110 001-34079 261482183 33 6256
2026-10-23 144 xsl144X01/primary_doc.xml 0001974078-26-000385 001-34079 261481837 33 4691
2026-10-21 8-K 8-K 5.02,9.01 0001140361-26-040377 001-34079 261475728 34 153854 1 1
2026-10-15 8-K 8-K 7.01,9.01 0001140361-26-039781 001-34079 261463754 34 7826383 1 1
2026-10-02 4 PRIMARY DOCUMENT 0002042266-26-000002 8588
2026-09-11 4 FORM 4 0001140361-26-036347 8994
2026-09-11 8-K 8-K 7.01,9.01 0001140361-26-036277 001-34079 261372692 34 7063647 1 1
2026-09-09 8-K 8-K 7.01,8.01,9.01 0001140361-26-035979 001-34079 261366674 34 8417272 1 1
2026-09-08 4 FORM 4 0001140361-26-035913 9590
2026-09-08 4 FORM 4 0001140361-26-035912 6025
2026-09-03 144 xsl144X01/primary_doc.xml 0001974158-26-000100 001-34079 261358480 33 5552
2026-08-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002668 333-298100 261284610 33 2043
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352641 005-79996 261283743 34 12094
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000020 005-79996 261282687 34 10262
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003425 005-79996 261275811 34 15720
2026-08-13 CORRESP filename1.htm 0001140361-26-032692 8433
2026-08-12 UPLOAD filename1.pdf 0000000000-26-007928 333-298100 148079
2026-08-07 S-3 S-3 0001140361-26-031740 333-298100 261251041 33 1647852 1 1
2026-08-06 10-Q 10-Q 0001628280-26-054381 001-34079 261249740 34 7345555 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001628280-26-053824 001-34079 261245898 34 248492 1 1
2026-07-27 4 FORM 4 0000905148-26-003354 5272
2026-07-27 4 FORM 4 0000905148-26-003353 5258
2026-07-27 4 FORM 4 0000905148-26-003352 5763
2026-07-27 4 FORM 4 0000905148-26-003351 5790
2026-07-23 144 xsl144X01/primary_doc.xml 0001974158-26-000091 001-34079 261197925 33 5392
2026-07-23 144 xsl144X01/primary_doc.xml 0001974158-26-000090 001-34079 261197891 33 5400
2026-07-23 144 xsl144X01/primary_doc.xml 0001974078-26-000274 001-34079 261196310 33 5299
2026-07-23 144 xsl144X01/primary_doc.xml 0001974078-26-000273 001-34079 261196240 33 5386
2026-06-17 424B2 424B2 0001140361-26-025525 333-296551 261096593 33 226088
2026-06-16 8-K 8-K 7.01,9.01 0001140361-26-025440 001-34079 261094751 34 198891 1 1
2026-06-16 8-K 8-K 7.01,9.01 0001140361-26-025363 001-34079 261093532 34 17429620 1 1
2026-06-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002021 333-296551 261096497 33 2041
2026-06-11 CORRESP filename1.htm 0001140361-26-024928 8645
2026-06-10 UPLOAD filename1.pdf 0000000000-26-005851 333-296551 148431
2026-06-05 S-3 S-3 0001140361-26-024283 333-296551 261069654 33 563188
2026-05-20 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-233062 005-79996 261005553 34 11018
2026-05-20 4 PRIMARY DOCUMENT 0002042266-26-000001 8130
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062694 005-79996 26988919 34 11350
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226555 005-79996 26986542 34 12116
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000010 005-79996 26983927 34 10318
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225195 005-79996 26982036 34 141916
2026-05-14 S-8 S-8 0001628280-26-035079 333-295887 26978812 33 237492 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001791917-26-000005 005-79996 26971754 34 25659
2026-05-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002950 005-79996 26971388 34 16461
2026-05-12 10-Q 10-Q 0001628280-26-034084 001-34079 26968351 34 5912871 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001628280-26-033856 001-34079 26965814 34 234144 1 1
2026-04-27 4 FORM 4 0000905148-26-001867 5790
2026-04-27 4 FORM 4 0000905148-26-001866 5287
2026-04-27 4 FORM 4 0000905148-26-001865 5772
2026-04-27 4 FORM 4 0000905148-26-001864 5256
2026-04-27 4 FORM 4 0000905148-26-001863 5789
2026-04-27 4 FORM 4 0000905148-26-001862 5787
2026-04-24 8-K 8-K 2.03 0001140361-26-016764 001-34079 26895641 34 154844 1 1
2026-04-23 144 xsl144X01/primary_doc.xml 0001974078-26-000152 001-34079 26889989 33 5250
2026-04-23 144 xsl144X01/primary_doc.xml 0001974078-26-000151 001-34079 26889948 33 4623
2026-04-23 144 xsl144X01/primary_doc.xml 0001974078-26-000149 001-34079 26889203 33 5239
2026-04-23 144 xsl144X01/primary_doc.xml 0001974078-26-000148 001-34079 26888698 33 4604
2026-04-23 144 xsl144X01/primary_doc.xml 0001974078-26-000147 001-34079 26888298 33 5183
2026-04-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001295 333-294295 26885354 33 2040
2026-04-22 4 FORM 4 0000905148-26-001788 5165
2026-04-22 4 FORM 4 0000905148-26-001787 5121
2026-04-22 4 FORM 4 0000905148-26-001786 5132
2026-04-22 4 FORM 4 0000905148-26-001785 6442
2026-04-22 4 FORM 4 0000905148-26-001784 5124
2026-04-22 4 FORM 4 0000905148-26-001782 5159
2026-04-22 4 FORM 4 0000905148-26-001781 5157
2026-04-22 8-K 8-K 5.07 0001140361-26-015990 001-34079 26881168 34 177151 1 1
2026-04-21 CORRESP filename1.htm 0001140361-26-015777 8539
2026-04-21 S-3/A S-3/A 0001140361-26-015733 333-294295 26876398 33 408700
2026-04-07 8-K 8-K 5.02,9.01 0001140361-26-013481 001-34079 26842887 34 189574 1 1
2026-04-07 8-K 8-K 1.01,3.02,7.01,9.01 0001140361-26-013394 001-34079 26842586 34 1354820 1 1
2026-03-23 ARS ARS 0001140361-26-010758 001-34079 26782268 34 978136
2026-03-23 DEF 14A DEF 14A 0001140361-26-010757 001-34079 26782242 34 7600591 1 1
2026-03-18 4 FORM 4 0000905148-26-001384 5216
2026-03-18 4 FORM 4 0000905148-26-001382 5181
2026-03-18 4 FORM 4 0000905148-26-001381 5705
2026-03-18 4 FORM 4 0000905148-26-001380 5720
2026-03-17 UPLOAD filename1.pdf 0000000000-26-002709 333-294295 40328
2026-03-16 144 xsl144X01/primary_doc.xml 0001974078-26-000120 001-34079 26757631 33 4603
2026-03-13 S-3 S-3 0001140361-26-009408 333-294295 26753256 33 539488 1 1
2026-03-12 PRE 14A PRE 14A 0001140361-26-009254 001-34079 26748739 34 7566947 1 1
2026-03-12 10-K 10-K 0001140361-26-009247 001-34079 26748661 34 11970430 1 1
2026-03-10 8-K 8-K 2.02,9.01 0001140361-26-008621 001-34079 26737190 34 302244 1 1
2026-02-19 8-K 8-K 1.01,2.02,3.02,5.03,8.01,9.01 0001140361-26-006176 001-34079 26654225 34 829459 1 1
2026-02-17 4 FORM 4 0000905148-26-000904 5024
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054534 005-79996 26640606 34 12029
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-052859 005-79996 26636077 34 126937
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015341 005-79996 26634399 34 11644
2026-01-26 4 xslF345X05/form4.xml 0000905148-26-000359 4907
2026-01-26 4 xslF345X05/form4.xml 0000905148-26-000358 4881
2026-01-26 4 xslF345X05/form4.xml 0000905148-26-000357 4846
2026-01-26 4 xslF345X05/form4.xml 0000905148-26-000356 4895
2026-01-26 4 xslF345X05/form4.xml 0000905148-26-000355 4867
2026-01-26 4 xslF345X05/form4.xml 0000905148-26-000354 4861
2026-01-22 S-8 S-8 0001140361-26-002066 333-292886 26552404 33 209940 1 1
2026-01-21 4 xslF345X05/form4.xml 0000905148-26-000282 4842
2026-01-13 4 xslF345X05/form4.xml 0000905148-26-000164 4843
2026-01-12 8-K 8-K 7.01,9.01 0001140361-26-000913 001-34079 26524926 34 6526277 1 1
2026-01-08 4 xslF345X05/form4.xml 0000905148-26-000088 6000
2026-01-08 8-K 8-K 7.01,9.01 0001140361-26-000615 001-34079 26517351 34 188764 1 1
2026-01-05 4 xslF345X05/form4.xml 0000905148-26-000036 5006
2026-01-05 4 xslF345X05/form4.xml 0000905148-26-000031 5017
2026-01-05 4 xslF345X05/form4.xml 0000905148-26-000028 5044
2026-01-05 4 xslF345X05/form4.xml 0000905148-26-000027 5042
2025-12-31 4 xslF345X05/form4.xml 0000905148-25-004511 9587
2025-12-19 8-K 8-K 8.01 0001140361-25-046187 001-34079 251587528 34 149450 1 1
2025-12-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-316569 005-79996 251566338 34 10446
2025-12-11 4 PRIMARY DOCUMENT 0002042266-25-000003 8376
2025-11-12 10-Q 10-Q 0001140361-25-041547 001-34079 251468819 34 9043344 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001140361-25-041544 001-34079 251468711 34 341514 1 1
2025-11-06 8-K 8-K 1.01,8.01,9.01 0001140361-25-040796 001-34079 251458982 34 755567 1 1
2025-11-06 8-K FORM 8-K 7.01,8.01,9.01 0001140361-25-040675 001-34079 251456328 34 211761 1 1
2025-11-06 FWP FWP 0001140361-25-040673 333-276462 251456318 34 12690
2025-11-06 424B5 424B5 0001140361-25-040671 333-276462 251456311 33 689007
2025-11-05 4/A xslF345X05/form4.xml 0000905148-25-003777 5194
2025-11-04 4 xslF345X05/form4.xml 0000905148-25-003767 4554
2025-10-24 4 xslF345X05/form4.xml 0000905148-25-003670 4567
2025-09-30 8-K 8-K 7.01,8.01,9.01 0001140361-25-036637 001-34079 251358154 34 6835558 1 1
2025-09-26 S-8 S-8 0001140361-25-036321 333-290551 251351235 33 253221 1 1
2025-09-11 4 xslF345X05/form4.xml 0000905148-25-003320 7278
2025-09-11 3 xslF345X02/form3.xml 0000905148-25-003319 12657
2025-09-10 S-8 S-8 0001140361-25-034578 333-290173 251306529 33 258438 1 1
2025-09-02 8-K 8-K 5.02,7.01,9.01 0001140361-25-033668 001-34079 251286293 34 411213 1 1
2025-08-27 4 xslF345X05/form4.xml 0000905148-25-003152 4444
2025-08-27 4 xslF345X05/form4.xml 0000905148-25-003151 4449
2025-08-25 8-K 8-K 3.02 0001140361-25-032533 001-34079 251251933 34 161619 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078680 005-79996 251220036 34 11637
2025-08-13 10-Q 10-Q 0001140361-25-030836 001-34079 251212451 34 10025568 1 1
2025-08-13 8-K 8-K 2.02,9.01 0001140361-25-030822 001-34079 251212216 34 344714 1 1
2025-08-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-076281 005-79996 251203445 34 149760
2025-07-23 8-K 8-K 1.01,7.01,9.01 0001140361-25-026853 001-34079 251141670 34 184074 1 1
2025-06-26 424B5 424B5 0001140361-25-023739 333-276462 251075208 33 17820
2025-06-26 8-K 8-K 8.01,9.01 0001140361-25-023732 001-34079 251075043 34 188633 1 1
2025-06-25 8-K 8-K 5.02 0001140361-25-023648 001-34079 251073872 34 156872 1 1
2025-06-23 8-K 8-K 7.01,9.01 0001140361-25-023265 001-34079 251063046 34 174503 1 1
2025-06-20 8-K 8-K 1.01 0001140361-25-023172 001-34079 251061466 34 155610 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049511 005-79996 25954247 34 11517
2025-05-15 10-Q 10-Q 0001140361-25-019266 001-34079 25952441 34 7907063 1 1
2025-05-15 8-K 8-K 2.02,9.01 0001140361-25-019153 001-34079 25948905 34 357489 1 1
2025-05-06 4 PRIMARY DOCUMENT 0001578563-25-000238 11226
2025-05-06 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-064711 005-79996 25918630 34 130668
2025-05-02 4 xslF345X05/form4.xml 0000905148-25-001430 7228
2025-05-02 4 xslF345X05/form4.xml 0000905148-25-001429 7184
2025-05-02 4 xslF345X05/form4.xml 0000905148-25-001428 7194
2025-05-02 4 xslF345X05/form4.xml 0000905148-25-001427 7213
2025-05-02 4 xslF345X05/form4.xml 0000905148-25-001426 7187
2025-05-02 4 xslF345X05/form4.xml 0000905148-25-001425 7222
2025-05-02 4 xslF345X05/form4.xml 0000905148-25-001424 7220
2025-05-01 8-K 8-K 5.07 0001140361-25-016948 001-34079 25904038 34 185307 1 1
2025-04-14 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS 0001999371-25-004182 001-34079 25836119 34 36924898
2025-04-11 PX14A6G px14a6g14390002_04112025.htm 0000921895-25-001063 001-34079 25832663 34 38234
2025-04-11 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS 0001999371-25-004153 001-34079 25832419 34 49870
2025-04-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001068 333-285038 25829668 33 2040
2025-04-10 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS 0001999371-25-004114 001-34079 25829132 34 85973
2025-04-09 DFAN14A dfan14a14390002_04092025.htm 0000921895-25-001042 001-34079 25825785 34 11852
2025-04-09 CORRESP filename1.htm 0001140361-25-012998 8292
2025-04-08 CORRESP filename1.htm 0001140361-25-012884 54132
2025-04-08 S-3/A S-3/A 0001140361-25-012650 333-285038 25820249 33 444282
2025-04-07 CORRESP filename1.htm 0001140361-25-012652 22840
2025-04-07 DEFA14A ADDITIONAL DEFINITIVE PROXY MATERIAL 0001999371-25-003885 001-34079 25816536 34 53069
2025-04-04 8-K 8-K 1.02 0001140361-25-012366 001-34079 25815459 34 161945 1 1
2025-04-04 424B5 PROSPECTUS SUPPLEMENT 0001140361-25-012357 333-276462 25815102 33 11971
2025-04-04 PRRN14A prrn14a14390002_04042025.htm 0000921895-25-000985 001-34079 25815070 34 547611
2025-04-02 DEFC14A PRELIMINARY PROXY STATEMENT 0001999371-25-003703 001-34079 25806214 34 6550625 1 1
2025-04-02 DFAN14A dfan14a14390002_04022025.htm 0000921895-25-000939 001-34079 25805220 34 1082586
2025-03-31 10-K 10-K 0001140361-25-011410 001-34079 25794934 34 14283507 1 1
2025-03-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-047708 005-79996 25793273 34 25542
2025-03-31 PRER14A PRELIMINARY PROXY STATEMENT 0001999371-25-003436 001-34079 25789244 34 3456121
2025-03-31 8-K 8-K 2.02,9.01 0001140361-25-011181 001-34079 25789053 34 622280 1 1
2025-03-28 UPLOAD filename1.pdf 0000000000-25-003401 001-34079 51346
2025-03-28 DFAN14A dfan14a14390002_03282025.htm 0000921895-25-000909 001-34079 25786895 34 17119
2025-03-26 4 xslF345X05/form4.xml 0000905148-25-001007 7552
2025-03-26 4 xslF345X05/form4.xml 0000905148-25-001006 7439
2025-03-24 8-K 8-K 3.02,8.01,9.01 0001140361-25-010064 001-34079 25765176 34 864800 1 1
2025-03-24 424B5 424B5 0001140361-25-009961 333-276462 25762208 33 9128741
2025-03-21 DFAN14A dfan14a14390002_03212025.htm 0000921895-25-000854 001-34079 25761646 34 33433
2025-03-21 PRER14A PRELIMINARY PROXY STATEMENT 0001999371-25-002993 001-34079 25761014 34 1307849
2025-03-21 PREC14A prec14a14390002_03202025.htm 0001193805-25-000336 001-34079 25759808 34 456469
2025-03-21 FWP FWP 0001140361-25-009812 333-276462 25758596 34 6729
2025-03-20 8-K 8-K 2.02,9.01 0001140361-25-009729 001-34079 25757842 34 168012 1 1
2025-03-20 FWP FWP 0001140361-25-009728 333-276462 25757826 34 9488132
2025-03-20 424B5 424B5 0001140361-25-009727 333-276462 25757821 33 9127922
2025-03-20 PREC14A PRELIMINARY PROXY STATEMENT 0001999371-25-002912 001-34079 25756520 34 1284288
2025-03-20 8-K CURRENT REPORT 5.03,8.01,9.01 0001999371-25-002866 001-34079 25754681 34 418714 1 1
2025-03-17 4 xslF345X05/form4.xml 0000905148-25-000942 7203
2025-03-17 4 xslF345X05/form4.xml 0000905148-25-000941 7154
2025-03-17 4 xslF345X05/form4.xml 0000905148-25-000940 7179
2025-03-17 4 xslF345X05/form4.xml 0000905148-25-000939 7182
2025-03-17 4 xslF345X05/form4.xml 0000905148-25-000938 7190
2025-03-17 4 xslF345X05/form4.xml 0000905148-25-000937 7175
2025-03-04 8-K 8-K 8.01 0001140361-25-006961 001-34079 25705739 34 166920 1 1
2025-02-26 UPLOAD filename1.pdf 0000000000-25-002222 333-285038 43455
2025-02-18 S-3 S-3 0001140361-25-005026 333-285038 25636187 33 533976
2025-02-18 4 xslF345X05/form4.xml 0000905148-25-000713 4524
2025-02-18 4 xslF345X05/form4.xml 0000905148-25-000712 4531
2025-02-07 DFAN14A dfan14a14390002_02072025.htm 0000921895-25-000281 001-34079 25600189 34 44704
2025-02-06 4 xslF345X05/form4.xml 0000905148-25-000403 13832
2025-02-06 4 xslF345X05/form4.xml 0000905148-25-000401 13950
2025-01-24 8-K 8-K 5.02,9.01 0001140361-25-001899 001-34079 25554628 34 383106 1 1
2025-01-23 8-K 8-K 8.01 0001140361-25-001819 001-34079 25551012 34 166477 1 1
2025-01-14 8-K FORM 8-K 8.01,9.01 0001140361-25-001013 001-34079 25527890 34 602695 1 1
2025-01-13 424B5 424B5 0001140361-25-000950 333-276462 25527170 33 605379
2025-01-07 8-K/A 8-K/A 9.01 0001140361-25-000467 001-34079 25515664 34 1553006 1 1
2025-01-06 4 xslF345X05/form4.xml 0000905148-25-000039 5043
2025-01-06 4 xslF345X05/form4.xml 0000905148-25-000038 5081
2024-12-30 4 xslF345X05/form4.xml 0000905148-24-003425 5137
2024-12-23 4 xslF345X05/form4.xml 0000905148-24-003406 4874
2024-11-25 4 xslF345X05/form4.xml 0000905148-24-003268 4632
2024-11-19 4 xslF345X05/form4.xml 0000905148-24-003236 7030
2024-11-12 4 xslF345X05/form4.xml 0000905148-24-003015 4951
2024-11-12 10-Q 10-Q 0001140361-24-046045 001-34079 241444165 34 8678681 1 1
2024-11-12 8-K 8-K 2.02,9.01 0001140361-24-046028 001-34079 241443696 34 796022 1 1
2024-11-07 D xslFormDX01/primary_doc.xml 06b 0001140361-24-045485 021-528843 241432910 33 16678
2024-11-05 4 xslF345X05/form4.xml 0000905148-24-002934 4575
2024-11-04 S-8 S-8 0001140361-24-045118 333-282988 241424601 33 135459
2024-10-29 SC 13D SC 13D 0001193125-24-246646 005-79996 241406803 34 97369
2024-10-29 3 PRIMARY DOCUMENT 0001578563-24-000432 18194
2024-10-24 4 xslF345X05/form4.xml 0000905148-24-002828 5398
2024-10-24 4 xslF345X05/form4.xml 0000905148-24-002827 7095
2024-10-24 3 xslF345X02/form3.xml 0000905148-24-002826 12744
2024-10-24 3 xslF345X02/form3.xml 0000905148-24-002824 12604
2024-10-24 3 xslF345X02/form3.xml 0000905148-24-002822 12626
2024-10-22 8-K 8-K 1.01,2.01,2.02,3.02,3.03,5.02,5.03,7.01,9.01 0001140361-24-043915 001-34079 241387005 34 6255652 1 1
2024-08-13 10-Q 10-Q 0001140361-24-037068 001-34079 241201416 34 7151103 1 1
2024-08-13 8-K 8-K 2.02,9.01 0001140361-24-036944 001-34079 241198875 34 357533 1 1
2024-06-13 4 xslF345X05/form4.xml 0000905148-24-001714 16733
2024-06-13 4 xslF345X05/form4.xml 0000905148-24-001713 7185
2024-06-13 4 xslF345X05/form4.xml 0000905148-24-001712 16688
2024-06-13 4 xslF345X05/form4.xml 0000905148-24-001711 16709
2024-06-13 4 xslF345X05/form4.xml 0000905148-24-001710 16679
2024-06-13 4 xslF345X05/form4.xml 0000905148-24-001709 16718
2024-06-13 8-K 8-K 5.03,5.07,9.01 0001140361-24-030012 001-34079 241041253 34 519182 1 1
2024-05-30 DEFR14A DEFR14A 0001140361-24-028123 001-34079 241005661 34 39280
2024-05-24 4 xslF345X05/form4.xml 0000905148-24-001625 4497
2024-05-21 4 xslF345X05/form4.xml 0000905148-24-001568 5044
2024-05-10 10-Q 10-Q 0001140361-24-025481 001-34079 24935532 34 6580700 1 1
2024-05-10 8-K 8-K 7.01,9.01 0001140361-24-025476 001-34079 24935413 34 2683282 1 1
2024-05-10 8-K 8-K 2.02,9.01 0001140361-24-025329 001-34079 24932944 34 330742 1 1
2024-04-29 ARS ARS 0001140361-24-023047 001-34079 24891962 34 1213986
2024-04-29 DEFA14A DEFA14A 0001140361-24-023044 001-34079 24891931 34 794765
2024-04-29 DEF 14A DEF 14A 0001140361-24-023004 001-34079 24891390 34 3894541
2024-04-19 PRE 14A PRE 14A 0001140361-24-020836 001-34079 24859019 34 3996155
2024-04-17 8-K 8-K 5.02,9.01 0001140361-24-020320 001-34079 24851359 34 351353 1 1
2024-04-15 4 xslF345X05/form4.xml 0000905148-24-001166 16340
2024-03-27 8-K 8-K 7.01,9.01 0001140361-24-015624 001-34079 24791112 34 6141789 1 1
2024-03-25 4 xslF345X05/form4.xml 0000905148-24-000999 14933
2024-03-25 4 xslF345X05/form4.xml 0000905148-24-000997 4489
2024-03-20 4 xslF345X05/form4.xml 0000905148-24-000991 5110
2024-03-08 10-K 10-K 0001140361-24-012399 001-34079 24735625 34 13608693 1 1
2024-03-08 8-K 8-K 2.02,9.01 0001140361-24-012128 001-34079 24732418 34 402589 1 1
2024-02-16 424B3 424B3 0001140361-24-008374 333-276462 24648889 33 293515
2024-02-16 8-K 8-K 5.02,9.01 0001140361-24-008352 001-34079 24648261 34 371013 1 1
2024-02-14 4 xslF345X05/form4.xml 0000905148-24-000743 7130
2024-02-14 4 xslF345X05/form4.xml 0000905148-24-000742 7136
2024-02-14 3 xslF345X02/form3.xml 0000905148-24-000741 12469
2024-02-14 3 xslF345X02/form3.xml 0000905148-24-000739 12604
2024-01-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-01-23 16:30:00 9999999995-24-000183 333-276462 24554135 33 1991
2024-01-22 4 FORM 4 0001140361-24-003192 7060
2024-01-22 4 FORM 4 0001140361-24-003191 7061
2024-01-22 CORRESP filename1.htm 0001140361-24-003036 9424
2024-01-19 UPLOAD filename1.pdf 0000000000-24-000762 333-276462 40531
2024-01-12 4 FORM 4 0001140361-24-002128 4506
2024-01-12 4 FORM 4 0001140361-24-002127 4504
2024-01-12 4 FORM 4 0001140361-24-002126 4506
2024-01-11 S-8 S-8 0001140361-24-001937 333-276471 24529443 33 185562
2024-01-10 S-3 S-3 0001140361-24-001759 333-276462 24527179 33 2252919
2024-01-03 4 xslF345X05/form4.xml 0001140361-24-000498 5102
2024-01-03 4 FORM 4 0001140361-24-000496 5096
2024-01-03 4 FORM 4 0001140361-24-000494 5138
2024-01-03 4 FORM 4 0001140361-24-000491 5099
2023-12-06 8-K 8-K 5.02,9.01 0001140361-23-056425 001-34079 231468120 34 388625 1 1
2023-12-05 4 xslF345X05/form4.xml 0001140361-23-056374 7146
2023-11-27 4 xslF345X05/form4.xml 0001140361-23-054744 5401
2023-11-27 3 xslF345X02/form3.xml 0001140361-23-054741 8365
2023-11-27 8-K 8-K 5.02,7.01,9.01 0001140361-23-054632 001-34079 231437408 34 324979 1 1
2023-11-21 S-8 S-8 0001140361-23-054063 333-275673 231424192 33 139205
2023-11-13 4 xslF345X05/form4.xml 0001140361-23-052988 4550
2023-11-13 4 xslF345X05/form4.xml 0001140361-23-052986 4567
2023-11-13 10-Q 10-Q 0001140361-23-052749 001-34079 231395512 34 7710060 1 1
2023-11-13 8-K 8-K 2.02,9.01 0001140361-23-052736 001-34079 231395298 34 362926 1 1
2023-11-03 4 xslF345X05/form4.xml 0001140361-23-051320 7012
2023-11-03 3 xslF345X02/form3.xml 0001140361-23-051318 11010
2023-11-02 8-K 8-K 7.01,8.01,9.01 0001140361-23-051009 001-34079 231370277 34 9292549 1 1
2023-11-01 8-K 8-K 5.02,7.01,8.01,9.01 0001140361-23-050844 001-34079 231368561 34 483461 1 1
2023-09-27 8-K 8-K 8.01,9.01 0001140361-23-045418 001-34079 231281929 34 211088 1 1
2023-08-14 424B5 424B5 0001140361-23-039413 333-252715 231166390 33 1388890
2023-08-11 8-K 8-K 1.01,2.02,9.01 0001140361-23-039201 001-34079 231161845 34 1166143 1 1
2023-08-11 10-Q 10-Q 0001140361-23-039196 001-34079 231161701 34 6652329 1 1
2023-08-01 8-K 8-K 7.01,9.01 0001140361-23-037246 001-34079 231130246 34 9331363 1 1
2023-07-12 UPLOAD filename1.pdf 0000000000-23-007426 39959
2023-07-07 CORRESP filename1.htm 0001140361-23-033736 10052
2023-06-28 UPLOAD filename1.pdf 0000000000-23-006872 44494
2023-06-14 8-K 8-K 5.02 0001140361-23-029848 001-34079 231014562 34 160935 1 1
2023-06-09 8-K 8-K 5.07 0001140361-23-029009 001-34079 231003210 34 178810 1 1
2023-06-08 4 xslF345X04/form4.xml 0001140361-23-029024 7084
2023-06-08 4 xslF345X04/form4.xml 0001140361-23-029023 7048
2023-06-08 4 xslF345X04/form4.xml 0001140361-23-029022 7076
2023-06-08 4 xslF345X04/form4.xml 0001140361-23-029021 7051
2023-06-08 4 xslF345X04/form4.xml 0001140361-23-029020 7077
2023-06-02 8-K 8-K 5.03,9.01 0001140361-23-028066 001-34079 23989317 34 179915 1 1
2023-05-15 10-Q 10-Q 0001140361-23-024504 001-34079 23918585 34 6250663 1 1
2023-05-15 8-K 8-K 2.02,7.01,9.01 0001140361-23-024502 001-34079 23918539 34 7074515 1 1
2023-05-01 ARS ARS 0001140361-23-022055 001-34079 23873876 34 5670507
2023-05-01 DEF 14A DEF 14A 0001140361-23-022044 001-34079 23873772 34 3161216
2023-04-26 4 xslF345X04/form4.xml 0001140361-23-020662 6937
2023-04-26 3 xslF345X02/form3.xml 0001140361-23-020660 15454
2023-04-21 4 xslF345X04/form4.xml 0001140361-23-019677 5012
2023-04-21 4 xslF345X04/form4.xml 0001140361-23-019676 5015
2023-04-21 4 xslF345X04/form4.xml 0001140361-23-019675 4673
2023-04-21 4 xslF345X04/form4.xml 0001140361-23-019674 5039
2023-04-21 8-K 8-K 5.02,7.01,9.01 0001140361-23-019505 001-34079 23834616 34 203591 1 1
2023-04-05 S-8 S-8 0001140361-23-016754 333-271150 23803392 33 200306
2023-03-30 10-K 10-K 0001140361-23-014868 001-34079 23781623 34 11356240 1 1
2023-03-30 8-K 8-K 2.02,9.01 0001140361-23-014674 001-34079 23777384 34 414463 1 1
2023-02-14 SC 13G/A SC 13G/A 0001140361-23-006889 005-79996 23627872 34 67613
2023-02-14 5 xslF345X03/form5.xml 0001140361-23-006840 7352
2023-02-14 5 xslF345X03/form5.xml 0001140361-23-006838 4416
2023-01-25 8-K 8-K 7.01,8.01,9.01 0001140361-23-002726 001-34079 23552643 34 6872127 1 1
2023-01-12 4 xslF345X03/form4.xml 0001140361-23-001520 7614
2023-01-12 4 xslF345X03/form4.xml 0001140361-23-001517 4961
2023-01-12 4 xslF345X03/form4.xml 0001140361-23-001516 7226
2023-01-12 4 xslF345X03/form4.xml 0001140361-23-001514 5005
2023-01-12 4 xslF345X03/form4.xml 0001140361-23-001513 6920
2023-01-12 4 xslF345X03/form4.xml 0001140361-23-001508 6898
2023-01-12 4 xslF345X03/form4.xml 0001140361-23-001504 4964
2023-01-06 4 xslF345X03/form4.xml 0001140361-23-000746 6674
2022-12-06 8-K 8-K 8.01,9.01 0001140361-22-044521 001-34079 221446660 34 197621 1 1
2022-11-07 8-K 8-K 1.01,9.01 0001140361-22-040303 001-34079 221365672 34 686276 1 1
2022-11-04 10-Q 10-Q 0001140361-22-040029 001-34079 221362970 34 6257394 1 1
2022-11-04 8-K 8-K 2.02,9.01 0001140361-22-040018 001-34079 221362823 34 344656 1 1
2022-10-20 4 xslF345X03/form4.xml 0001140361-22-037954 6678
2022-10-14 8-K 8-K 7.01,9.01 0001140361-22-037191 001-34079 221310627 34 11482567 1 1
2022-10-12 4 xslF345X03/form4.xml 0001140361-22-036952 6639
2022-10-04 4 xslF345X03/form4.xml 0001140361-22-035953 6689
2022-09-08 4 FORM 4 0001140361-22-032758 6789
2022-08-12 10-Q 10-Q 0001140361-22-029461 001-34079 221161007 34 5703205 1 1
2022-08-12 8-K 8-K 2.02,7.01,9.01 0001140361-22-029352 001-34079 221157855 34 11479759 1 1
2022-07-06 4 FORM 4 0001140361-22-025289 6909
2022-07-06 4 FORM 4 0001140361-22-025286 6950
2022-07-06 4 FORM 4 0001140361-22-025284 4997
2022-07-06 4 FORM 4 0001140361-22-025282 5024
2022-06-17 8-K 8-K 5.03,5.07,9.01 0001140361-22-023457 001-34079 221023775 34 209449 1 1
2022-06-15 4 FORM 4 0001140361-22-023052 5300
2022-06-15 4 FORM 4 0001140361-22-023051 5285
2022-06-15 4 FORM 4 0001140361-22-023050 5256
2022-06-15 4 FORM 4 0001140361-22-023049 5259
2022-06-15 4 FORM 4 0001140361-22-023048 5284
2022-06-15 4 FORM 4 0001140361-22-023047 5292
2022-06-10 DEFA14A DEFA14A 0001140361-22-022604 001-34079 221009116 34 18924
2022-06-10 8-K 8-K 5.03,9.01 0001140361-22-022593 001-34079 221009061 34 179919 1 1
2022-06-02 DEFA14A DEFA14A 0001140361-22-021621 001-34079 22991233 34 12392
2022-05-24 4 FORM 4 0001140361-22-020364 4287
2022-05-23 4 FORM 4 0001140361-22-020274 6698
2022-05-19 8-K 8-K 7.01,8.01,9.01 0001140361-22-019865 001-34079 22941160 34 14697332 1 1
2022-05-17 SC 13G SCHEDULE 13G 0001213900-22-027670 005-79996 22935109 34 124836
2022-05-13 10-Q 10-Q 0001140361-22-019002 001-34079 22920461 34 5258181 1 1
2022-05-13 8-K 8-K 2.02,9.01 0001140361-22-018973 001-34079 22920326 34 327808 1 1
2022-04-28 8-K 8-K 8.01,9.01 0001140361-22-016342 001-34079 22862171 34 210334 1 1
2022-04-27 DEFA14A DEFA14A 0001140361-22-016116 001-34079 22856636 34 3321850
2022-04-27 DEF 14A DEF 14A 0001140361-22-016115 001-34079 22856628 34 2184103
2022-04-13 4 FORM 4 0001140361-22-014327 5351
2022-04-05 S-8 S-8 0001140361-22-013147 333-264139 22807048 33 250894
2022-04-05 4 FORM 4 0001140361-22-013064 4871
2022-04-05 4 FORM 4 0001140361-22-013060 4912
2022-03-29 8-K 8-K 7.01,8.01,9.01 0001140361-22-011507 001-34079 22777503 34 7990352 1 1
2022-03-24 10-K 10-K 0001140361-22-011015 001-34079 22767345 34 10083617 1 1
2022-03-24 8-K 8-K 2.02,9.01 0001140361-22-010857 001-34079 22764756 34 400616 1 1
2022-02-14 SC 13G/A SC 13G/A 0001140361-22-005284 005-79996 22631801 34 67312
2022-02-14 SC 13G/A AMENDMENT TO SC 13G 0001387131-22-001770 005-79996 22626429 34 128950
2022-02-14 5 FORM 5 0001140361-22-005102 4436
2022-02-01 4 FORM 4 0001140361-22-003497 5362
2022-02-01 4 FORM 4 0001140361-22-003495 5373
2022-02-01 4 FORM 4 0001140361-22-003492 5346
2022-01-31 8-K 8-K 7.01,9.01 0001140361-22-003200 001-34079 22571687 34 24325835 1 1
2022-01-31 8-K 8-K 8.01,9.01 0001140361-22-003143 001-34079 22571140 34 206897 1 1
2022-01-18 SC 13G/A OCUPHIRE PHARMA, INC. 0000902664-22-000300 005-79996 22534165 34 78080
2022-01-05 4 FORM 4 0001140361-22-000659 4938
2022-01-05 4 FORM 4 0001140361-22-000658 4897
2022-01-05 8-K 8-K 7.01,9.01 0001140361-22-000594 001-34079 22509420 34 11590054 1 1
2021-12-14 4 FORM 4 0001140361-21-041622 4315
2021-11-22 4 FORM 4 0001140361-21-038872 4763
2021-11-15 8-K 8-K 2.02,7.01,9.01 0001140361-21-037932 001-34079 211412423 34 12952555 1 1
2021-11-12 10-Q 10-Q 0001140361-21-037545 001-34079 211399939 34 6736982 1 1
2021-10-04 4 FORM 4 0001140361-21-033449 4901

Latest XBRL company facts

One latest value per concept from companyfacts (391 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 96.65M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
dei EntityPublicFloat Entity Public Float USD 45.90M 2025-06-30 2025 FY 10-K 2026-03-12 0001140361-26-009247
ffd NetFeeAmt NetFeeAmt USD 32,142.12 2026-08-07 S-3 2026-08-07 0001140361-26-031740
ffd TtlFeeAmt TtlFeeAmt USD 32,142.12 2026-08-07 S-3 2026-08-07 0001140361-26-031740
ffd TtlOfferingAmt TtlOfferingAmt USD 300.00M 2026-08-07 S-3 2026-08-07 0001140361-26-031740
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-07 S-3 2026-08-07 0001140361-26-031740
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-07 S-3 2026-08-07 0001140361-26-031740
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 1.07 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-07 0001140361-15-030473
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 2.26M 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 2.26M 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AccountsPayableTradeCurrentAndNoncurrent Accounts Payable, Trade USD 1.84M 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 4,864 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 6.11M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4.49M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 287,300 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 753,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AccruedRentCurrentAndNoncurrent Accrued Rent USD 13,678 2018-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 25,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001140361-24-046045
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD 0 2011-12-31 2011 FY 10-K 2012-03-16 0001140361-12-016054
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 346.03M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 173.54M 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 5.00M 2026-04-02 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 64,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.59M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.08M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.28M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap Assets Assets USD 95.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AssetsCurrent Assets, Current USD 94.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 3.00M 2019-12-31 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 14.97M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 0 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 2,084 2019-12-31 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 12,602 2019-03-31 2019 Q1 10-Q 2019-05-10 0001140361-19-008945
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 3.00M 2019-12-31 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 3.00M 2019-12-31 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 3.00M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 2.96M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 USD 100,000 2014-09-30 2014 Q3 10-Q 2014-11-12 0001140361-14-041326
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 USD 100,000 2014-09-30 2014 Q3 10-Q 2014-11-12 0001140361-14-041326
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 11.98M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 11.92M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 14.88M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 2,340 2010-12-31 2012 FY 10-K 2013-03-22 0001140361-13-013730
us-gaap BilledContractReceivables Billed Contracts Receivable USD 1.50M 2019-12-31 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 1.12M 2020-11-05 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap BusinessAcquisitionSharePrice Business Acquisition, Share Price USD/shares 7.24 2020-11-05 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 10.46M 2020-11-05 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap CashAcquiredInExcessOfPaymentsToAcquireBusiness Cash Acquired in Excess of Payments to Acquire Business USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 88.97M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -154,853 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 8.10M 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 89.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 14.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 43.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 17.02M 2022-06-30 2022 Q2 10-Q 2022-08-12 0001140361-22-029461
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 38.70M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001140361-23-024504
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 9.6 2019-01-25 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 19.62M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001628280-26-054381
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap CommonStockSharesHeldInEmployeeTrustShares Common Stock, Shares Held in Employee Trust, Shares shares 800,000 2013-12-31 2013 FY 10-K 2014-03-21 0001140361-14-013828
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 95.80M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 95.80M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 30,000 2017-03-31 2017 Q1 10-Q 2017-05-03 0001140361-17-018125
us-gaap CommonStockValue Common Stock, Value, Issued USD 10,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -119.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -63.31M 2001-03-19 2012-12-31 2012 FY 10-K 2013-03-22 0001140361-13-013730
us-gaap ContractsReceivableClaimsAndUncertainAmountsExpectedToBeCollectedWithinOneYear Contracts Receivable, Claims and Uncertain Amounts, Expected to be Collected in Next Twelve Months USD 4,671 2012-06-30 2012 Q2 10-Q 2012-08-08 0001140361-12-035725
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 650,000 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 24.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 7.37M 2026-04-20 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 100,000 2009-01-01 2009-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD -1.63M 2001-03-19 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 552,627 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 88,000 2021-03-31 2021 Q1 10-Q 2021-05-07 0001140361-21-016458
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 1.30M 2026-04-02 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 30,000 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 19,900 2018-12-31 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap DeferredRevenue Deferred Revenue USD 0 2023-12-31 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 862,500 2011-06-30 2011 Q2 10-Q 2011-08-09 0001140361-11-040635
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD -37,500 2011-01-01 2011-06-30 2011 Q2 10-Q 2011-08-09 0001140361-11-040635
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 484,000 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 40.03M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.45M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 30,000 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 32.25M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 15.70M 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 700,000 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 329,000 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.90M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.94M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 4,000 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 40.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 30,000 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 28,854 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.02 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.03 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001140361-13-019748
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.03 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap Depreciation Depreciation USD 49,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 27,013 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 21.32M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001140361-25-041547
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 11.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 328,937 2009-06-04 2009-06-05 2013 FY 10-K 2014-03-21 0001140361-14-013828
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 87.41M 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001628280-26-054381
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.27 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -5.28 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.27 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.093 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.031 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001140361-23-014868
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.068 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.56M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 126,198 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 5.70M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 0.73 2014-08-01 2014 Q3 10-Q 2014-11-12 0001140361-14-041326
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 71.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-13 0001140361-22-019002
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-13 0001140361-22-019002
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -68.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 2.64M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-22 0001140361-13-013730
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 34.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -72.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -9,594 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 1.77M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 17.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 286,132 2001-03-19 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 286,132 2009-01-01 2009-12-31 2013 FY 10-K 2014-03-21 0001140361-14-013828
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001140361-23-052749
us-gaap IncentiveFromLessor Incentive from Lessor USD 154,660 2018-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest USD -11.34M 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-16 0001140361-12-016054
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -4.50M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -120.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001628280-26-034084
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 4.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -10.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 421,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 264,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 3.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 848,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 434,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 992,750 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -990,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -850,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD 18,682 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-21 0001140361-14-013828
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 5,751 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 772,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001628280-26-054381
us-gaap InterestExpense Interest Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 222,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap InterestExpenseOther Interest Expense, Other USD 301,147 2001-03-19 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 301,147 2001-03-19 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 651,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 42,235 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 100,000 2014-06-30 2014 Q2 10-Q 2014-08-13 0001140361-14-032243
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 22,650 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 48,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-07 0001140361-21-016458
us-gaap LeaseCost Lease, Cost USD 125,638 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.11 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 104,583 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 36,000 2023-12-31 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 65,364 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 65,364 2020-06-30 2020 Q2 10-Q 2020-08-14 0001140361-20-018406
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 155,280 2019-12-31 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 39,219 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4,186 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap Liabilities Liabilities USD 56.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 95.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LiabilitiesCurrent Liabilities, Current USD 9.83M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 45.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 100,000 2009-01-01 2009-12-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap LitigationSettlementAmount Litigation Settlement, Amount (Deprecated 2017-01-31) JPY 210.00M 2016-12-19 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap LitigationSettlementGross Litigation Settlement, Gross (Deprecated 2013-01-31) USD 100,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001140361-13-019748
us-gaap LongTermDebt Long-term Debt USD 35.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 34.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.20M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001628280-26-034084
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -13,301 2001-03-19 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 10.71M 2011-12-31 2011 FY 10-K 2012-03-16 0001140361-12-016054
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 82.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 22.11M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -189,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -9.37M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -38.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -15.42M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -120.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -73.63M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001628280-26-054381
us-gaap NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Other Liabilities Assumed USD 9,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001140361-23-039196
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -84,222 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap NotesAndLoansReceivableGrossCurrent Financing Receivable, before Allowance for Credit Loss, Current USD 18,682 2011-12-31 2012 FY 10-K 2013-03-22 0001140361-13-013730
us-gaap NotesAndLoansReceivableGrossNoncurrent Financing Receivable, before Allowance for Credit Loss, Noncurrent USD 0 2011-12-31 2011 FY 10-K 2012-03-16 0001140361-12-016054
us-gaap NotesAssumed1 Notes Assumed USD 9.37M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure USD 1.30M 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap NotesReceivableGross Financing Receivable, before Allowance for Credit Loss USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap NotesReceivableRelatedPartiesCurrent Notes Receivable, Related Parties, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap NumberOfOperatingSegments Number of Operating Segments obligation 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap NumberOfReportableSegments Number of Reportable Segments obligation 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap OperatingExpenses Operating Expenses USD 54.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -50.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap OperatingLeaseCost Operating Lease, Cost USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 100,397 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 100,397 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 63,605 2019-12-31 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OperatingLeasePayments Operating Lease, Payments USD 116,061 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 106,126 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 210,548 2018-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 176,080 2018-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 34,468 2016-09-30 2016 Q3 10-Q 2016-11-04 0001140361-16-084902
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 34,468 2017-09-30 2017 Q3 10-Q 2017-11-03 0001140361-17-040967
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 34,468 2018-09-30 2018 Q3 10-Q 2018-11-02 0001140361-18-042255
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 34,468 2018-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 34,468 2015-09-30 2015 Q3 10-Q 2015-11-02 0001140361-15-039272
us-gaap OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths Operating Leases, Future Minimum Payments, Next Rolling Twelve Months USD 36,000 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 100,210 2013-07-01 2015 Q3 10-Q 2015-11-02 0001140361-15-039272
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 31.50M 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 221,170 2019-12-31 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OtherAssetsCurrent Other Assets, Current USD 86,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001140361-24-046045
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent USD 2,340 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-22 0001140361-13-013730
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 2,340 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-21 0001140361-14-013828
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 1.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2,084 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2,084 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 2,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001140361-21-028115
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap OtherPaymentsToAcquireBusinesses Other Payments to Acquire Businesses USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 605,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 651,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 28,410 2001-03-19 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 1.57M 2020-11-05 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 19,383 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 8.89M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 189,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 901,297 2014-06-30 2014 Q2 10-Q 2014-08-13 0001140361-14-032243
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.25M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 343,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001140361-24-046045
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap ProceedsFromHedgeFinancingActivities Proceeds from Hedge, Financing Activities USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 5.15M 2001-03-19 2014-03-31 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 25.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 9.24M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-02 0001140361-18-042255
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 3.00M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 5,500 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001140361-23-014868
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 15.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 25,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001140361-24-046045
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 339,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap RecapitalizationCosts Recapitalization Costs USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD 1.50M 2003-01-01 2003-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 30.00M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001140361-14-041326
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 837,991 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 36.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 179,673 2011-01-19 2012 Q3 10-Q 2012-11-08 0001140361-12-046272
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 196,130 2013-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011969
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -308.72M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 4.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 3.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap Revenues Revenues USD 1.15M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 380,935 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap SecurityDeposit Security Deposit USD 25,681 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap SecurityDepositLiability Security Deposit Liability USD 25,681 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011969
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001628280-26-054381
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 6.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 2.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0.95 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.75 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.31 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.014 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.008 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 17.00M 2006-06-02 2013 Q1 10-Q 2013-05-09 0001140361-13-019748
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 6.83M 2013-03-31 2013 Q1 10-Q 2013-05-09 0001140361-13-019748
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 10,600 2016-03-31 2016 Q1 10-Q 2016-05-06 0001140361-16-063841
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 7.93M 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.78 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 730,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 886,958 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.93M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.65 2020-06-01 2020-06-30 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 53,883 2017-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.52M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001140361-18-021763
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.62 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 0.92 2012-09-30 2012 Q3 10-Q 2012-11-08 0001140361-12-046272
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.8 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001140361-16-057543
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 1.37 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.89 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.31 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001140361-17-009132
us-gaap SharePrice Share Price USD/shares 9.6 2019-01-25 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap ShortTermBorrowings Short-term Debt USD 600,000 2021-11-30 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.055 2023-12-31 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap ShortTermInvestments Short-term Investments USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 38.43M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.057 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap StockIssued1 Stock Issued USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001140361-25-011410
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 19.05M 2014-01-20 2014-01-21 2014 Q1 10-Q 2014-05-14 0001140361-14-020971
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 118,465 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 7.09M 2020-11-05 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 464 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001140361-19-019932
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 25,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001140361-19-004539
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 8.12M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001140361-22-011015
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 94.23M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 73,000 2014-08-01 2014 FY 10-K 2015-03-16 0001140361-15-011969
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 22,650 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-21 0001140361-20-003785
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 610,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 57,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 1,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 372,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 500,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001140361-23-052749
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-08 0001140361-24-012399
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 24.74M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001628280-26-034084
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 7.37M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001628280-26-034084
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 24.74M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 128,410 2015-12-03 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2015-12-31 2015 FY 10-K 2016-03-14 0001140361-16-057543
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 11,321 2015-12-03 2017 FY 10-K 2018-03-09 0001140361-18-012817
us-gaap TreasuryStockValue Treasury Stock, Value USD 128,410 2014-12-31 2015 FY 10-K 2016-03-14 0001140361-16-057543
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 28,410 2006-01-01 2006-12-31 2013 FY 10-K 2014-03-21 0001140361-14-013828
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0001140361-23-014868
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001140361-26-009247
us-gaap VariableLeaseCost Variable Lease, Cost USD 15,327 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001140361-20-024042
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 11.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 94.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 4.66M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001140361-21-008099
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 94.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072697

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →